News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Brand Insights - Thought Leadership | Paid Program | Veradigm

Understanding the Impact of the Veradigm Network on Value-Based Healthcare Delivery

ByAmanda Cohen, MPH
June 1st 2024

Comparing Registry and Electronic Health Record Data for Real-World Evidence Generation: Heart Failure as a Case Study

ByMac Bonafede, VP of Research Consulting, Veradigm
November 29th 2022

Contrasting the view of heart failure patients as seen from the perspectives of two large but distinct sources of real-world data: the Veradigm Cardiology Registry and Practice Fusion

Advertisement
Advertisement

Trending on PharmExec

1

Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection

2

Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals

3

When Ambition Meets Ambiguity: The Trends and Sentiments Shaping Biotech in 2026

4

JCA vs. Reality: Europe’s Push for Clinical Harmonization

5

FDA Reveals New Guidance for Streamlining Biosimilar Development

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us